168 related articles for article (PubMed ID: 17485967)
1. Blood pressure and lipid goal attainment in the hypertensive population in the primary care setting in Spain.
Barrios V; Escobar C; Calderón A; Llisterri JL; Echarri R; Alegría E; Muñiz J; Matalí A
J Clin Hypertens (Greenwich); 2007 May; 9(5):324-9. PubMed ID: 17485967
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol goal attainment in hypertensive patients: the impact of metabolic syndrome components.
Rodrigues CJ; Ribeiro HF; Ribeiro AB; Zanella MT; Batista MC
Metab Syndr Relat Disord; 2012 Jun; 10(3):195-201. PubMed ID: 22313142
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy.
Yan X; Li Y; Dong Y; Wu Y; Li J; Bian R; Hu D
Lipids Health Dis; 2019 Jan; 18(1):32. PubMed ID: 30696435
[TBL] [Abstract][Full Text] [Related]
4. The COSEHC™ Global Vascular Risk Management quality improvement program: first follow-up report.
Ferrario CM; Joyner J; Colby C; Exuzides A; Moore M; Simmons D; Bestermann W; Frech-Tamas F
Vasc Health Risk Manag; 2013; 9():391-400. PubMed ID: 23901282
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia.
Chopra I; Kamal KM
Hosp Pract (1995); 2014 Apr; 42(2):77-88. PubMed ID: 24769787
[TBL] [Abstract][Full Text] [Related]
6. Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008.
Kuznik A; Mardekian J
Cardiovasc Diabetol; 2011 Apr; 10():31. PubMed ID: 21496321
[TBL] [Abstract][Full Text] [Related]
7. [Diabetes mellitus in hypertensive population attended in Primary Care in Spain. Blood pressure and lipid control rates].
Escobar C; Barrios V; Calderón A; Llisterri JL; García S; Rodríguez-Roca GC; Matalí A
Rev Clin Esp; 2007 May; 207(5):221-7. PubMed ID: 17504665
[TBL] [Abstract][Full Text] [Related]
8. PREVALENCE, TREATMENT AND CONTROL OF HYPERTENSION AMONG TYPE 2 DIABETIC PATIENTS AT MOI TEACHING AND REFERRAL HOSPITAL, ELDORET, KENYA.
Ndege BW; Diero LO; Owiti MO; Anjichi G; Siika AM
East Afr Med J; 2014 Aug; 91(8):253-60. PubMed ID: 26862649
[TBL] [Abstract][Full Text] [Related]
9. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN
Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156
[TBL] [Abstract][Full Text] [Related]
10. Attainment of normal lipid levels among high cardiovascular risk patients: pooled analysis of observational studies from the United Kingdom, Sweden, Spain and Canada.
Ambegaonkar BM; Bash LD; Chirovsky DR; Jameson K; Grant S; Nocea G; Pettersson B; Sazonov V
Eur J Intern Med; 2013 Oct; 24(7):656-63. PubMed ID: 23953848
[TBL] [Abstract][Full Text] [Related]
11. The association of blood lipid parameters variability with ischemic stroke in hypertensive patients.
Huang YQ; Liu L; Liu XC; Lo K; Tang ST; Feng YQ; Zhang B
Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1521-1532. PubMed ID: 33810958
[TBL] [Abstract][Full Text] [Related]
12. Assessing the impact of medication use on trends in major coronary risk factors in older British men: a cohort study.
Hardoon SL; Whincup PH; Wannamethee SG; Lennon LT; Capewell S; Morris RW
Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):502-8. PubMed ID: 20386311
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk factor control is insufficient in young patients with coronary artery disease.
Christiansen MK; Jensen JM; Brøndberg AK; Bøtker HE; Jensen HK
Vasc Health Risk Manag; 2016; 12():219-27. PubMed ID: 27307744
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure and lipid control status in Japanese hypertensive patients.
Ohta Y; Tsuchihashi T; Morinaga Y; Onaka U; Ueno M
Clin Exp Hypertens; 2009 Jun; 31(4):298-305. PubMed ID: 19811358
[TBL] [Abstract][Full Text] [Related]
15. Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.
Gitt AK; Drexel H; Feely J; Ferrières J; Gonzalez-Juanatey JR; Thomsen KK; Leiter LA; Lundman P; da Silva PM; Pedersen T; Wood D; Jünger C; Dellea PS; Sazonov V; Chazelle F; Kastelein JJ;
Eur J Prev Cardiol; 2012 Apr; 19(2):221-30. PubMed ID: 21450578
[TBL] [Abstract][Full Text] [Related]
16. [Blood pressure and lipid control and coronary risk in the hypertensive population attended in Primary Care setting in Spain. The PRESCOT study].
Barrios V; Escobar C; Llisterri JL; Calderón A; Alegría E; Muñiz J; Matalí A
Rev Clin Esp; 2007 Apr; 207(4):172-8. PubMed ID: 17475179
[TBL] [Abstract][Full Text] [Related]
17. Effect of bezafibrate on office, home and ambulatory blood pressure in hypertensive patients with dyslipidemia.
Ohta Y; Kawano Y; Iwashima Y; Hayashi S; Yoshihara F; Nakamura S
J Hum Hypertens; 2013 Jul; 27(7):417-20. PubMed ID: 23254592
[TBL] [Abstract][Full Text] [Related]
18. [Impact of the presence of cardiovascular disease on blood pressure and lipid control in the hypertense population attended in primary care].
Barrios Alonso V; Escobar Cervantes C; Calderón Montero A; Llisterri Caro JL; Echarri Carrillo R; Matalí A
Aten Primaria; 2008 Jan; 40(1):21-7. PubMed ID: 18190764
[TBL] [Abstract][Full Text] [Related]
19. Achievement of multiple therapeutic targets for cardiovascular disease prevention: Retrospective analysis of real practice in Italy.
Figliuzzi I; Presta V; Citoni B; Miceli F; Simonelli F; Battistoni A; Coluccia R; Ferrucci A; Volpe M; Tocci G
Clin Cardiol; 2018 Jun; 41(6):788-796. PubMed ID: 29604091
[TBL] [Abstract][Full Text] [Related]
20. Association between blood pressure, the treatment of hypertension, and cardiovascular risk factors in women.
Nanchahal K; Ashton WD; Wood DA
J Hypertens; 2000 Jul; 18(7):833-41. PubMed ID: 10930179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
